PF-02341066 (Crizotinib)
-
Technical Data
Description
PF-02341066 (Crizotinib) is an orally bioavailable agent belonging to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors with potential antineoplastic activity.